16:11 EDT Tenaya Therapeutics (TNYA) files $300M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNYA:
- Tenaya Therapeutics: Strong Financial Position and Promising Clinical Trial Results Justify Buy Rating
- Biotech Alert: Searches spiking for these stocks today
- Promising Clinical Data and Financial Stability Support Buy Rating for Tenaya Therapeutics Despite Price Target Reduction
- Tenaya Therapeutics price target lowered to $6 from $18 at Canaccord
- Buy Rating for Tenaya Therapeutics: Strong Clinical Progress and Financial Stability